Retatrutide Split Dosing: A Precision Approach to Optimizing Multi-Pathway Metabolic Signaling
Retatrutide is redefining metabolic research with its triple agonist design, but how it’s dosed may be just as important as the compound itself. This deep-dive explores why splitting your weekly dose into 2–3 administrations can create more stable receptor activation, improved tolerability, and more consistent metabolic signaling—along with how these principles extend to tirzepatide and semaglutide.